Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey

Overview

Journal J Health Care Poor Underserved

Publisher Johns Hopkins University Press

Date 2019 May 28

PMID 31130545

Citations 10

Authors

Jennifer Tsui

Adana A Llanos

Michelle Doose

David Rotter

Antoinette Stroup

Affiliations

Soon will be listed here.

Abstract

Objectives: To identify determinants of follow-up care and diagnosis of invasive cervical cancer among uninsured/underinsured women screened for cervical cancer.

Methods: We examined the associations between health care facility, area-level, and individual-level factors on the outcomes of interest in retrospective cohort of women from the New Jersey Cancer Education and Early Detection Program (2000-2015).

Results: Women screened at department of health clinics (aOR:3.11, 95% CI: 2.30-4.20) and health care system-affiliated clinics (aOR:1.71, 95% CI: 1.11-2.64) had higher odds of lacking follow-up care compared with women in private physician practices. Similarly, women residing in areas with the highest unemployment had higher odds of lacking follow-up (aOR:1.48, 95% CI: 1.07-2.06). Delays in follow-up care were higher for women born in Central/South American countries compared with U.S.-born women (aOR: 1.46, 95% CI: 1.12-1.92).

Conclusions: Improved outreach efforts and multilevel strategies are needed to address the persistent barriers to appropriate follow-up care for underserved women.

Citing Articles

Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.

Bukowski A, Hoyo C, Vielot N, Graff M, Kosorok M, Brewster W BMC Cancer. 2023; 23(1):1072.

PMID: 37932662 PMC: 10629205. DOI: 10.1186/s12885-023-11518-6.

Uptake of a Cervical Cancer Clinical Decision Support Tool: A Mixed-Methods Study.

Huguet N, Ezekiel-Herrera D, Gunn R, Pierce A, OMalley J, Jones M Appl Clin Inform. 2023; 14(3):594-599.

PMID: 37532232 PMC: 10411153. DOI: 10.1055/s-0043-1769913.

Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown".

Kohler R, Hemler J, Wagner R, Sullivan B, Macenat M, Tagai E Patient Educ Couns. 2023; 114:107810.

PMID: 37244133 PMC: 10527466. DOI: 10.1016/j.pec.2023.107810.

Cervical Cancer Screening Among Older Garifuna Women Residing in New York City.

Rockson L, Btoush R J Racial Ethn Health Disparities. 2023; 11(3):1600-1610.

PMID: 37212964 DOI: 10.1007/s40615-023-01635-0.

Reallocating Cervical Cancer Preventive Service Spending from Low- to High-Value Clinical Scenarios.

Rockwell M, Armbruster S, Capucao J, Russell K, Rockwell J, Perkins K Cancer Prev Res (Phila). 2023; 16(7):385-391.

PMID: 36976753 PMC: 10320459. DOI: 10.1158/1940-6207.CAPR-22-0531.

References

Spence A, Goggin P, Franco E . Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med. 2007; 45(2-3):93-106. DOI: 10.1016/j.ypmed.2007.06.007. View

Benard V, Lee N, Piper M, Richardson L . Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States). Cancer Causes Control. 2001; 12(1):61-8. DOI: 10.1023/a:1008959019019. View

Wilbur D, Nayar R . Bethesda 2014: improving on a paradigm shift. Cytopathology. 2016; 26(6):339-42. DOI: 10.1111/cyt.12300. View

Bazargan M, Bazargan S, Farooq M, Baker R . Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med. 2004; 39(3):465-73. DOI: 10.1016/j.ypmed.2004.05.003. View

Plascak J, Llanos A, Pennell M, Weier R, Paskett E . Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test. Cancer Epidemiol Biomarkers Prev. 2014; 23(12):2819-28. PMC: 4257881. DOI: 10.1158/1055-9965.EPI-14-0348. View

Watson M, Benard V, Flagg E . Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014. Prev Med Rep. 2018; 9:124-130. PMC: 5840841. DOI: 10.1016/j.pmedr.2018.01.010. View

Ramachandran A, Snyder F, Katz M, Darnell J, Dudley D, Patierno S . Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program. Cancer. 2015; 121(22):4016-24. PMC: 4675460. DOI: 10.1002/cncr.29607. View

Smith J, Brewer N, Saslow D, Alexander K, Chernofsky M, Crosby R . Recommendations for a national agenda to substantially reduce cervical cancer. Cancer Causes Control. 2013; 24(8):1583-93. PMC: 5333930. DOI: 10.1007/s10552-013-0235-8. View

Solomon D, Davey D, Kurman R, Moriarty A, OConnor D, Prey M . The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287(16):2114-9. DOI: 10.1001/jama.287.16.2114. View

10.

Taplin S, Anhang Price R, Edwards H, Foster M, Breslau E, Chollette V . Introduction: Understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr. 2012; 2012(44):2-10. PMC: 3482968. DOI: 10.1093/jncimonographs/lgs008. View

11.

Tsui J, Saraiya M, Thompson T, Dey A, Richardson L . Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Womens Health (Larchmt). 2007; 16(10):1447-57. DOI: 10.1089/jwh.2006.0279. View

12.

Miller J, Hanson V, Johnson G, Royalty J, Richardson L . From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer. 2014; 120 Suppl 16:2549-56. PMC: 4459516. DOI: 10.1002/cncr.28823. View

13.

Fontaine P, Saslow D, King V . ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer. Am Fam Physician. 2012; 86(6):501, 506-7. View

14.

Elit L, Saskin R, Raut R, Elliott L, Murphy J, Marrett L . Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort. Gynecol Oncol. 2012; 128(1):95-100. DOI: 10.1016/j.ygyno.2012.10.006. View

15.

Leyden W, Manos M, Geiger A, Weinmann S, Mouchawar J, Bischoff K . Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005; 97(9):675-83. DOI: 10.1093/jnci/dji115. View

16.

Battaglia T, Bak S, Heeren T, Chen C, Kalish R, Tringale S . Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev. 2012; 21(10):1645-54. PMC: 3472624. DOI: 10.1158/1055-9965.EPI-12-0532. View

17.

Ramachandran A, Freund K, Bak S, Heeren T, Chen C, Battaglia T . Multiple barriers delay care among women with abnormal cancer screening despite patient navigation. J Womens Health (Larchmt). 2014; 24(1):30-6. PMC: 4361220. DOI: 10.1089/jwh.2014.4869. View

18.

Eggleston K, Coker A, Das I, Cordray S, Luchok K . Understanding barriers for adherence to follow-up care for abnormal pap tests. J Womens Health (Larchmt). 2007; 16(3):311-30. DOI: 10.1089/jwh.2006.0161. View

19.

Rojas C, Zhou M, Khamis H, Amesse L . Analysis of patterns of patient compliance after an abnormal Pap smear result: the influence of demographic characteristics on patient compliance. J Low Genit Tract Dis. 2013; 17(3):298-302. DOI: 10.1097/LGT.0b013e31826b683e. View

20.

Benard V, Howe W, Royalty J, Helsel W, Kammerer W, Richardson L . Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt). 2012; 21(7):776-82. PMC: 4545597. DOI: 10.1089/jwh.2011.3224. View